Cargando…
Real-life data on tapering or discontinuation of canakinumab therapy in patients with familial Mediterranean fever
This study aimed to investigate the disease characteristics of familial Mediterranean fever (FMF) patients undergoing dose optimisation and discontinuation of canakinumab therapy. A total of 61 patients diagnosed with FMF and using canakinumab for the resistant disease were enrolled on this retrospe...
Autores principales: | Karabulut, Yusuf, Gezer, Halise Hande, Öz, Nuran, Esen, İrfan, Duruöz, Mehmet Tuncay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434546/ https://www.ncbi.nlm.nih.gov/pubmed/36048189 http://dx.doi.org/10.1007/s00296-022-05199-w |
Ejemplares similares
-
Clinical features, functional status, and quality of life in patients with late-onset familial Mediterranean fever
por: Gursoy, Didem Erdem, et al.
Publicado: (2023) -
Ultrasound Measurement of Femoral Cartilage Thickness in Patients with Familial Mediterranean Fever and its Relation to Amyloidosis and Other Disease Characteristics
por: Gezer, Halise Hande, et al.
Publicado: (2022) -
Validity and reliability of the Mini-Osteoarthritis Knee and Hip Quality of Life scale in Turkish population
por: Tuncay Duruöz, Mehmet, et al.
Publicado: (2021) -
The impact of COVID-19 on familial Mediterranean fever: a nationwide study
por: Günendi, Zafer, et al.
Publicado: (2021) -
Canakinumab therapy in patients with Familial Mediterranean Fever
por: Ugurlu, S, et al.
Publicado: (2015)